At-Home vs. In-Clinic Ketamine Therapy

The emergence of telehealth ketamine platforms has created a new option: receiving sublingual ketamine therapy at home guided by a clinician over video call. Here is how this compares to in-clinic IV or IM ketamine treatment.

In-Clinic Treatment

In-clinic options include IV infusion (100% bioavailability, most studied), IM injection (~93% bioavailability, no IV needed), and Spravato (FDA-approved, self-administered in certified settings). Advantages include full medical supervision, emergency equipment on-site, precise dosing, deeper therapeutic experiences, and potential insurance coverage for Spravato. Disadvantages include high cost ($400-$800/session for IV), travel requirements, limited to clinic hours, and reduced accessibility in rural areas.

At-Home Telehealth

How telehealth programs work: Video intake consultation with a licensed provider, prescription of sublingual ketamine lozenges (mailed to your home), sessions at home guided by audio or video, and regular check-ins with your care team. Cost: typically $129-$350/month, dramatically less than IV infusion.

Advantages of At-Home Treatment

Key benefits of telehealth ketamine:

• Significantly lower cost (often 10x less expensive than IV series)
• Accessible from anywhere with internet connection
• Flexible scheduling around your lifestyle
• Many patients relax more deeply in home environment
• Ongoing monthly programs provide sustained care

Limitations of At-Home Treatment

Important limitations to understand:

• Lower bioavailability (~25-30% sublingual vs. 100% IV)
• Less precise dosing than IV infusion
• No in-person emergency backup if something goes wrong
• Less intense experiences than IV; may be less effective for severe cases
• Not appropriate for patients with complex medical or psychiatric histories

Who Is Right for Each?

At-home telehealth suits patients with mild to moderate symptoms, no complex medical history, rural location, or significant cost constraints. In-clinic treatment is preferable for severe or treatment-resistant depression, complex psychiatric or medical history, chronic pain conditions, or when Spravato is covered by insurance. Many patients use telehealth for ongoing maintenance between clinic-based induction series.